Standing up in public for a broader conception of value in healthcare.

49-56 of 60 News

viewpoint 11/10/16

Lakdawalla and Goldman in STAT News: "Pharma Needs a New Prescription" In the wake of the election, IVI's Exective Director Darius Lakdawalla and Co-Chair of the Panel of Health Advisors Dana Goldman provide a "policy prescription list" to enable lower prices and improved patient access without discouraging medical innovation, in a new commentary for STAT News. READ MORE

viewpoint 11/04/16

On the Health Affairs Blog: Regulatory, Legal Uncertainties Are Barriers To Value-Based Agreements Alison Sexton Ward, Mark Linthicum, Michelle Drozd, Alison Silverstein, and Joe Vandigo share the results of their interviews with a group of five stakeholders regarding their experience with value-based agreements. READ MORE

viewpoint 9/22/16

On the Health Affairs Blog: Lakdawalla and Neumann discuss problems with adding budget criteria to value assessments on Health Affairs Blog Darius Lakdawalla and Peter Neumann discuss the use of explicit budget impact criteria in value assessment in a piece published today on the Heath Affairs blog. READ MORE

viewpoint 9/15/16

On the Health Affairs Blog: Goldman, Nussbaum, and Linthicum discuss the need for innovation in pricing and value measurement In an inaugural post to the Health Affairs blog series on “Drugs and Medical Innovation,” Dana Goldman, Samuel Nussbaum, and Mark Linthicum discuss the need for innovation in pricing and value measurement READ MORE

viewpoint 8/26/16

Goldman tackles EpiPen pricing controversy in STAT News Goldman addresses the firestorm created by Mylan's dramatic price hikes for their EpiPen in a new commentary published in STAT News: "To Prevent Another EpiPen Controversy, the Government Should Step In." READ MORE

viewpoint 8/13/16

Shafrin and Philipson in Forbes: Are you just a number? In Tomas Philipson's latest op-ed, he and co-author Jason Shafrin describe the potential for new value frameworks to undermine the ability of patients and providers to find the best treatment for a specific patient READ MORE

viewpoint 8/02/16

Chandra responds to President Obama on the ACA in JAMA editorial Amitabh Chandra and co-author Jonathan Skinner respond to President Obama’s JAMA letter describing the success of the ACA READ MORE

viewpoint 7/07/16

Darius Lakdawalla in the AP: A Model for More Rational Drug Prices Darius Lakdawalla is featured in The AP's Big Story READ MORE